Ishmeet S Juneja Joins Robins Appleby’s Litigation Group
Robins Appleby LLP is pleased to announce that Ishmeet S Juneja has joined the firm as an associate in our Litigation and Dispute Resolution Group.
September 15, 2026
Associate announcement
Michael Sgro joins Smart & Biggar, Canada’s leading firm for intellectual property law, adding to the depth and breadth of the firm’s patent practice in Ottawa.
September 12, 2019
Michael Sgro joins Smart & Biggar, Canada’s leading firm for intellectual property law, adding to the depth and breadth of the firm’s patent practice in Ottawa.
Michael’s experience covers the pharmaceutical and chemical patent fields. He specializes in chemical compositions, small molecules (NCEs), semiconductors, polymers, catalysts and catalytic processes, and manufacturing processes and apparatuses. He works with new technologies; particularly those relating to new drugs, specialty chemicals, industrial chemical processes and clean technologies. With his background expertise in chemistry and wide-ranging experience in several chemical fields, he is well-positioned to help inventors protect their inventions and leverage the value of their intellectual property assets. Prior to entering the legal field, Michael completed a Ph.D. in Chemistry at the University of Toronto and a postdoctoral fellowship at the University of Calgary.
Smart & Biggar is widely recognized as Canada’s leading intellectual property firm. We are leaders in intellectual property and have been serving clients for over a century. Smart & Biggar operates as part of the IPH Limited group, under its own brand and independent from other IPH member firms.
View All Announcements by This Firm
Robins Appleby LLP is pleased to announce that Ishmeet S Juneja has joined the firm as an associate in our Litigation and Dispute Resolution Group.
September 15, 2026
Smart & Biggar is pleased to welcome Associate, Ashley Lam to our Patents practice group.
September 14, 2026
Smart & Biggar is pleased to welcome Associate, Michael Kovacevic to our Life Sciences practice group.
September 14, 2026